-+ 0.00%
-+ 0.00%
-+ 0.00%

Jamjoom Pharmaceuticals Posts Higher H1 Net Profit, Revenue

MT Newswires·07/22/2026 02:06:12
Listen to the news
02:06 AM EDT, 07/22/2026 (MT Newswires) -- Jamjoom Pharmaceuticals Factory Co. (SASE:4015) said Wednesday its net attributable profit and revenue for the first half rose year over year. Net profit attributable to shareholders for the six months ended June 30 was 305.8 million Saudi riyals, compared with 289.1 million riyals earlier. EPS moved to 4.37 riyals from 4.13 riyals. The Tadawul-listed pharmaceutical company's revenue was 926.7 million riyals, compared with 853.8 million riyals a year ago. Meanwhile, the board proposed an interim dividend of 2.20 riyals per share, payable Aug. 13 to shareholders on record July 30. It paid 2 riyals per share for the year-ago period.